Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
2.92
-0.04 (-1.35%)
At close: Aug 15, 2025, 10:05 AM

Editas Medicine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
32.31M 78.12M 19.71M 25.54M
Cost of Revenue
5.81M 6.06M 6.34M 5.05M
Gross Profit
26.5M 72.06M 13.38M 20.49M
Operating Income
-238.92M -169.18M -225.95M -193.15M
Interest Income
14.06M 17.57M 5.52M 607K
Pretax Income
-237.09M -153.22M -220.43M -192.5M
Net Income
-237.09M -153.22M -220.43M -192.5M
Selling & General & Admin
71.99M 69.65M 70.7M 76.18M
Research & Development
199.25M 177.65M 174.96M 142.51M
Other Expenses
-5.81M -6.06M -6.34M -5.05M
Operating Expenses
265.43M 241.24M 239.32M 213.64M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
283.47M 247.3M 245.66M 218.69M
Income Tax Expense
n/a n/a -16.08M -7.39M
Shares Outstanding (Basic)
82.34M 75.97M 68.66M 67.62M
Shares Outstanding (Diluted)
82.34M 75.97M 68.66M 67.62M
EPS (Basic)
-2.88 -2.02 -3.21 -2.85
EPS (Diluted)
-2.88 -2.02 -3.21 -2.85
EBITDA
-233.11M -163.12M -219.61M -188.09M
EBIT
-238.92M -169.18M -225.95M -193.15M
Depreciation & Amortization
5.81M 6.06M 6.34M 5.05M